Carcinogenesis Advance Access originally published online on April 25, 2006
Carcinogenesis 2006 27(7):1301-1309; doi:10.1093/carcin/bgl024
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies
The Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA and 1 Department of Community, Occupational and Family Medicine, National University of Singapore, Singapore 117597
* To whom correspondence and requests for reprints should be addressed at: Division of Epidemiology and Community Health, School of Public Health University of Minnesota, 1300 South Second Street Suite 300, Minneapolis, MN, USA, Tel: 612 625 8056; Fax: 612 624 0315; Email: jyuan{at}umn.edu
Experimental studies have supported tea as a chemopreventive agent for colorectal cancer. No quantitative summary of the epidemiologic evidence on tea and colorectal cancer risk has ever been performed. The current meta-analysis included 25 papers conducted in 11 countries across three continents (North America, Asia and Europe). Summary odds ratios (ORs) for highest versus non/lowest tea consumption levels were calculated based on fixed and random effects models. The meta-regression and stratified methods were used to examine heterogeneity across studies. For green tea, the combined results from eight studies indicated a reduced risk of colorectal cancer with intake [summary OR = 0.82, 95% confidence interval (CI) = 0.69–0.98]. The protective effect is mainly found among the three case–control studies of colon cancer (summary OR = 0.74, 95% CI = 0.60–0.93). Results from studies of rectal cancer irrespective of study design (case–control versus cohort) (summary OR = 0.99, 95% CI = 0.71–1.37) and cohort studies of colon cancer (summary OR = 0.99, 95% CI = 0.79–1.24) were compatible with the null hypothesis. For black tea, the summary OR derived from 20 studies was 0.99 (95% CI = 0.87–1.13). There is wide divergence in results across the 20 individual studies; formal tests for homogeneity across studies revealed statistically significant differences in findings across all studies (P < 0.001), amongst the 7 cohort studies (P = 0.002), and amongst the 13 case–control studies (P < 0.001). Despite the strong evidence from in vitro and non-human in vivo studies in support of green and black tea as potential chemopreventive agents against colorectal cancer, available epidemiologic data are insufficient to conclude that either tea type may protect against colorectal cancer in humans.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. McLarty, R. L.H. Bigelow, M. Smith, D. Elmajian, M. Ankem, and J. A. Cardelli Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro Cancer Prevention Research, July 1, 2009; 2(7): 673 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lambert, S.-J. Kwon, J. Ju, M. Bose, M.-J. Lee, J. Hong, X. Hao, and C. S. Yang Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate Carcinogenesis, October 1, 2008; 29(10): 2019 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Auger, W. Mullen, Y. Hara, and A. Crozier Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy J. Nutr., August 1, 2008; 138(8): 1535S - 1542S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. W. Arts A Review of the Epidemiological Evidence on Tea, Flavonoids, and Lung Cancer J. Nutr., August 1, 2008; 138(8): 1561S - 1566S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Abrams Review: Chemoprevention of esophageal adenocarcinoma Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 T.-P. Ng, L. Feng, M. Niti, E.-H. Kua, and K.-B. Yap Tea consumption and cognitive impairment and decline in older Chinese adults Am. J. Clinical Nutrition, July 1, 2008; 88(1): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wang, W.M. Dashwood, C. V. Lohr, K. A. Fischer, C. B. Pereira, M. Louderback, H. Nakagama, G. S. Bailey, D. E. Williams, and R. H. Dashwood Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and {beta}-catenin expression in the rat Carcinogenesis, April 1, 2008; 29(4): 834 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xiao, X. Hao, B. Simi, J. Ju, H. Jiang, B. S. Reddy, and C. S. Yang Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats Carcinogenesis, January 1, 2008; 29(1): 113 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Sun, J.-M. Yuan, W. P. Koh, H.-P. Lee, and M. C. Yu Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study Carcinogenesis, October 1, 2007; 28(10): 2143 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yang, X.-O. Shu, H. Li, W.-H. Chow, B.-T. Ji, X. Zhang, Y.-T. Gao, and W. Zheng Prospective Cohort Study of Green Tea Consumption and Colorectal Cancer Risk in Women Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1219 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Carlson, B. A. Bauer, A. Vincent, P. J. Limburg, and T. Wilson Reading the Tea Leaves: Anticarcinogenic Properties of (-)-Epigallocatechin-3-Gallate Mayo Clin. Proc., June 1, 2007; 82(6): 725 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kuriyama, Y. Nishino, Y. Tsubono, and I. Tsuji Green Tea Consumption and Mortality in Japan--Reply JAMA, January 24, 2007; 297(4): 360 - 361. [Full Text] [PDF]
|
|